Nicotinic Agonist
Nicotinic acetylcholine receptor, Acetylcholine, Tobacco
978-620-1-60717-0
620160717X
88
2012-06-18
34,00 €
eng
https://images.our-assets.com/cover/230x230/9786201607170.jpg
https://images.our-assets.com/fullcover/230x230/9786201607170.jpg
https://images.our-assets.com/cover/2000x/9786201607170.jpg
https://images.our-assets.com/fullcover/2000x/9786201607170.jpg
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. A nicotinic agonist is a drug that mimics, in one way or another, the action of acetylcholine at nicotinic acetylcholine receptors. Nicotine has been known for centuries for its intoxicating effect. It was first isolated in 1828 from the tobacco plant by German chemists, Posselt and Reimann. The discovery of positive effects from nicotine on animal memory was discovered by in vivo researches in the middle of the 1980s. Those researches led to a new era in studies of nicotinic acetylcholine receptor and their stimulation but until then the focus had mainly been on nicotine addiction. The development of nAChR agonists began in the early 1990s after the discovery of nicotine’s positive effects.
https://morebooks.shop/books/hu/published_by/vent/193147/products
Kémia
https://morebooks.shop/store/hu/book/nicotinic-agonist/isbn/978-620-1-60717-0